Cellectar Biosciences, Inc. (CLRB)
2.69
+0.09
(+3.46%)
USD |
NASDAQ |
May 01, 16:00
2.76
+0.07
(+2.60%)
After-Hours: 20:00
Cellectar Biosciences Market Cap : 11.41M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint, Inc. | 1.112B |
| Ocugen, Inc. | 609.33M |
| ACADIA Pharmaceuticals, Inc. | 3.742B |
| Alnylam Pharmaceuticals, Inc. | 39.51B |
| Savara, Inc. | 1.048B |
Market Cap Related Metrics
| PEG Ratio | -0.0041 |
| Price to Book Value | 1.423 |
| Price | 2.69 |
| Earnings Yield | -229.9% |
| PEGY Ratio | -0.0041 |